Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic malignancy classified by WHO and marked by cutaneous lesions, bone marrow infiltration, and CNS involvement.

Accurate neoplasia detection in patients with Barrett esophagus (BE) involves high-quality endoscopy, adequate biopsy ...

Main pancreatic duct (MPD) dilation without an apparent obstructing lesion is an independent risk factor for neoplastic ...

WITH increasing use of new and more radical procedures for surgical palliation, with the increasing effectiveness of radiotherapy and chemotherapy in delaying, if not eliminating, the terminal ...

Blueprint Medicines BPMC announced positive top-line results from the Part 2 of PIONEER clinical trial of AYVAKIT (avapritinib) in patients with non-advanced systemic mastocytosis (SM). The Part 2 of ...

Scientists from the University of Texas MD Anderson Cancer Center say that they discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes ...

Diet quality and cardiometabolic risk factors among breast cancer survivors in the Pathways Study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include ...

SAN FRANCISCO - While commercially available optical tools can help clinicians identify premalignant lesions in the oral cavity, the prevalence of confounding lesions increases the rate of false ...

Please provide your email address to receive an email when new articles are posted on . Adjuvant low-dose rituximab in combination with plasma exchange and steroids appeared effective for the ...